All Biomarkers Content

Bringing you the latest research in biomarker development, diagnostics, precision medicine and more through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Key opinion leaders from GlaxoSmithKline and Weill Cornell Medicine discuss future perspectives on neuro-organoids.
By Tia Byer |
29 April 2022
Biomarkers for Clinical Development
Discussion Group Report
Jordi Clarimon, Lead Specialist in Fluid Biomarkers at Lundbeck, leads a discussion on ‘Fluid Biomarkers for Neurodegenerative Diseases.
By Tia Byer |
26 April 2022
Biomarkers for Clinical Development
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Translational Biomarkers to Guide Clinical Development of CAR T-Cells’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
31 March 2022
Biomarkers for Clinical Development
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group, focusing on ‘Using Biomarkers For Clinical Development & Regulatory Approval,’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
28 February 2022
Biomarkers for Clinical Development
Insight Article
How can the industry transform itself with improved biomarkers for clinical development? And what hurdles stand in the way? We sat down with senior representatives from Galapagos, Ohio State University, and Genentech to find out more.
By Tia Byer |
25 February 2022
Biomarkers for Clinical Development
Commentary
Melanie Anderson, Principal Scientist at MSD, on how the pandemic has made scientists rethink clinical trials.
By Tom Cohen |
21 February 2022
Biomarkers for Clinical Development
Video Content
Webinar
Presented by Marianne Scheel Fjording, Scientific Officer at BioAgilytix
06 July 2021
Biomarkers for Clinical Development
Video Content
Webinar
Webinar presented by Jeff Buckthal, Senior Business Development Manager at Owlstone Medical & Dr. Robert Mohney, Head of Clinical and Translational Science at Owlstone Medical
25 June 2021
Biomarkers for Clinical Development
Video Content
Webinar
Presented by Nicholas Jones, Director of Global Flow Cytometry- Pharma Services, Neogenomics Laboratories. Moderated by Ken Pennline, Consultant Pharma/Biotech, Redconsulting
26 May 2020
Biomarkers for Clinical Development
Written Q&A
Regent Laporte, Program Director, Specialized Certificate in Translational Science, Altman Clinical and Translational Research Institute, School of Medicine, University of California San Diego
08 October 2019
Biomarkers for Clinical Development

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login